These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26231487)

  • 1. Biomarkers in HCV Infection.
    Park SH; Bang CS; Kim DJ
    Adv Clin Chem; 2015; 70():131-96. PubMed ID: 26231487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons.
    Soriano V; García-Samaniego J
    HIV Clin Trials; 2002; 3(5):351-3. PubMed ID: 12407483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of HCV treatment: who does well and who does not?
    Hsu CS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis C virus genotype 3: that simple, yet that complex (corrected)].
    Batskikh SN; Morozov SV; Chulanov VP; Pokrovsky VI
    Ter Arkh; 2012; 84(11):4-10. PubMed ID: 23252240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego.
    Puoti M; Bruno R; Castelli F; Filice G; Carosi G
    HIV Clin Trials; 2002; 3(5):419-20. PubMed ID: 12407492
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
    el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
    Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
    Pár A; Vincze Á; Pár G
    Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis C].
    Grammatikos G; Sarrazin C
    Dtsch Med Wochenschr; 2010 Dec; 135(50):2525-34; quiz 2535-8. PubMed ID: 21140330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
    Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
    Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients.
    Lo Iacono O
    Rev Esp Enferm Dig; 2000 Aug; 92(8):485-94. PubMed ID: 11084816
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
    Asselah T; Bièche I; Paradis V; Bedossa P; Vidaud M; Marcellin P
    Semin Liver Dis; 2007 Feb; 27(1):13-27. PubMed ID: 17295174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic hepatitis C: etiology, pathogenesis, treatment].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(11):12-7. PubMed ID: 20143559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of hepatitis C cure with antivirals: why test and treat?
    Lledó G; Benítez-Gutiérrez L; Arias A; Requena S; Cuervas-Mons V; de Mendoza C
    Future Microbiol; 2019 Mar; 14():425-435. PubMed ID: 30900911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hepatic fibrosis in patients with chronic hepatitis C.
    Albanis E; Friedman SL
    Clin Liver Dis; 2006 Nov; 10(4):821-33. PubMed ID: 17164119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.